# FDA recall D-1202-2018

> **Hellolife** · Class I · drug recall initiated 2018-08-23.

## Product

Thyroveev, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512.  NDC: 49726-025-02

## Reason for recall

Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia

## Distribution

Nationwide USA, Algeria  Australia  Belgium  Brazil  Bulgaria  Canada  Colombia  Croatia  Cyprus  Czech Republic  Denmark  Dominican Republic  Ecuador  Estonia  French Polynesia  Greece  Guadeloupe  Guam  Hong Kong  Hungary  India  Ireland  Israel  Italy  Latvia  Lithuania  Martinique  Mexico  Monaco  Netherlands  New Zealand  Norway  Peru  Poland  Portugal  Romania  Russia  Russian Federation  Saudi Arabia  Senegal  Serbia  Slovakia  Slovakia (Slovak Republic)  Slovenia  Swaziland  Sweden  Switzerland  Taiwan  Turkey  United Kingdom

## Key facts

- **Recall number:** D-1202-2018
- **Recalling firm:** Hellolife
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-08-23
- **Report date:** 2018-09-19
- **Termination date:** 2021-01-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Grand Rapids, MI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1202-2018

## Citation

> AI Analytics. FDA recall D-1202-2018. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-1202-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*